LeMaitre Vascular, Inc.LMAT stock score: 65/100
$74.86 · -0.62% · Scored Nov 19, 2026
- Technical
- 37
- Fundamental
- 72
- News
- —
The reading
LeMaitre Vascular (LMAT) scores 65 out of 100, which reads neutral, higher than 90% of Healthcare stocks and 91% of the 4,118 US stocks we score.
The composite weights fundamentals 80% and technicals 20%: fundamentals read 72, technicals 37.
Among the fundamentals, Quick Ratio at 100 and Current Ratio at 100 score highest, while Inventory Turnover at 25 weighs the most against it.
On the daily chart, trend-following indicators average 16 and contrarian oscillators 77 — a split worth reading before trusting the technical total.
Since Aug 22, 2026 the composite has ranged from 54 to 66, and it is up 10 points over the period.
About LeMaitre Vascular
LeMaitre Vascular (LMAT) makes and sells medical devices, implants and human tissue grafts used mainly by vascular surgeons to treat peripheral vascular disease. Its products include valvulotomes used to prepare veins for bypass grafts, catheters, carotid shunts, synthetic vascular grafts and bovine pericardial patches used to close arteries after surgery. Its biologic products include Artegraft, a graft made from bovine carotid artery used for dialysis access and bypass, and RestoreFlow allografts, which are processed human veins and arteries supplied through its tissue processing services. Customers are hospitals, and LeMaitre reaches the surgeons who choose its products through its own direct sales force in the Americas, Europe and Asia-Pacific. It earns money from product and tissue sales, much of it from niche devices used in open vascular surgery that larger companies have deprioritized. LeMaitre has grown partly by acquiring small product lines.
LeMaitre competes with Getinge, Becton Dickinson, Terumo, W. L. Gore and Artivion, along with smaller device makers. Its edge rests on a broad catalog of specialized products for vascular surgeons, a direct sales force focused on that specialty and regular price increases supported by limited competition in niche categories. Investors who follow LMAT stock tend to watch organic sales growth, pricing and gross margin. Sales of Artegraft and RestoreFlow allografts, including the supply of donor tissue, are closely followed. Regulatory approvals in Europe and other markets, acquisitions, operating margins and dividends are other factors.
What’s driving the score
The strongest and weakest of the scorers that count toward LMAT’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
72Pulling it up
- Quick Ratio100
Quick ratio measures a company's ability to meet short-term obligations with liquid assets.
Current assets divided by current liabilities: the ability to pay short-term bills.
How the latest quarter's revenue compares with the average of the last four, plus a bonus for steady quarterly revenue.
Holding it back
Inventory turnover is how many times a year a company sells through its inventory.
Earnings estimates score evaluates analyst projections for future profitability.
Asset turnover is revenue divided by total assets: how much sales a company generates from each dollar of assets.
38 weighted scorers; 1 had no data today and are left out rather than counted as zero.
Technical · daily
25Pulling it up
Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.
Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.
Money Flow Index (14-period) is a volume-weighted RSI that identifies overbought and oversold conditions.
Holding it back
Where the price sits between its 52-week low and high.
Simple Moving Average (200-period) is the most widely followed long-term trend indicator.
- VWAP0
Volume Weighted Average Price (VWAP) shows the average price weighted by volume.
62 weighted scorers; 3 had no data today and are left out rather than counted as zero.
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 39 | 1 |
| Daily | 25 | 3 |
| Weekly | 25 | 2 |
| Monthly | 47 | 2 |
| Quarterly | 55 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Nov 19, 2026 | 65 |
| Nov 18, 2026 | 65 |
| Nov 17, 2026 | 65 |
| Nov 16, 2026 | 65 |
| Nov 15, 2026 | 65 |
| Nov 14, 2026 | 65 |
| Nov 13, 2026 | 65 |
| Nov 12, 2026 | 66 |
| Nov 11, 2026 | 55 |
| Nov 10, 2026 | 54 |
| Nov 8, 2026 | 55 |
| Nov 7, 2026 | 55 |
| Nov 6, 2026 | 55 |
| Nov 5, 2026 | 59 |
| Nov 4, 2026 | 57 |
| Nov 3, 2026 | 58 |
| Nov 2, 2026 | 57 |
| Nov 1, 2026 | 57 |
| Oct 31, 2026 | 57 |
| Oct 30, 2026 | 57 |
| Oct 29, 2026 | 60 |
| Oct 28, 2026 | 60 |
| Oct 27, 2026 | 59 |
| Oct 26, 2026 | 59 |
| Oct 25, 2026 | 60 |
| Oct 24, 2026 | 60 |
| Oct 23, 2026 | 60 |
| Oct 22, 2026 | 60 |
| Oct 21, 2026 | 60 |
| Oct 20, 2026 | 60 |
| Oct 19, 2026 | 58 |
| Oct 18, 2026 | 58 |
| Oct 17, 2026 | 58 |
| Oct 16, 2026 | 58 |
| Oct 15, 2026 | 60 |
| Oct 14, 2026 | 59 |
| Oct 13, 2026 | 59 |
| Oct 12, 2026 | 59 |
| Oct 11, 2026 | 58 |
| Oct 10, 2026 | 58 |
| Oct 9, 2026 | 58 |
| Oct 8, 2026 | 57 |
| Oct 7, 2026 | 56 |
| Oct 6, 2026 | 56 |
| Oct 5, 2026 | 58 |
| Oct 4, 2026 | 56 |
| Oct 3, 2026 | 56 |
| Oct 2, 2026 | 56 |
| Oct 1, 2026 | 56 |
| Sep 30, 2026 | 58 |
| Sep 29, 2026 | 58 |
| Sep 28, 2026 | 58 |
| Sep 27, 2026 | 58 |
| Sep 26, 2026 | 58 |
| Sep 25, 2026 | 58 |
| Sep 24, 2026 | 59 |
| Sep 23, 2026 | 58 |
| Sep 22, 2026 | 58 |
| Sep 21, 2026 | 56 |
| Sep 20, 2026 | 55 |
| Sep 19, 2026 | 55 |
| Sep 18, 2026 | 55 |
| Sep 17, 2026 | 55 |
| Sep 16, 2026 | 56 |
| Sep 15, 2026 | 56 |
| Sep 14, 2026 | 56 |
| Sep 13, 2026 | 56 |
| Sep 12, 2026 | 56 |
| Sep 11, 2026 | 57 |
| Sep 10, 2026 | 55 |
| Sep 9, 2026 | 55 |
| Sep 8, 2026 | 56 |
| Sep 7, 2026 | 56 |
| Sep 6, 2026 | 56 |
| Sep 5, 2026 | 56 |
| Sep 4, 2026 | 56 |
| Sep 3, 2026 | 58 |
| Sep 2, 2026 | 58 |
| Sep 1, 2026 | 58 |
| Aug 31, 2026 | 56 |
| Aug 30, 2026 | 56 |
| Aug 29, 2026 | 56 |
| Aug 28, 2026 | 57 |
| Aug 27, 2026 | 55 |
| Aug 26, 2026 | 55 |
| Aug 25, 2026 | 54 |
| Aug 24, 2026 | 54 |
| Aug 23, 2026 | 55 |
| Aug 22, 2026 | 55 |
Key facts
- Market cap
- $1.7B
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Beta
- 0.49
- Risk grade (1–10)
- 8
- Next earnings
- Nov 4, 2026
Medical Instruments & Supplies peers
| Company | Market cap | Score |
|---|---|---|
| WRBY Warby Parker | $3.0B | 59 |
| ATRC AtriCure | $2.8B | 58 |
| AZTA Azenta | $2.0B | 49 |
| XRAY DENTSPLY SIRONA | $1.7B | 46 |
| KMTS Kestra Medical Technologies | $1.6B | 50 |
| STAA STAAR Surgical Company | $1.3B | 53 |
All Medical Instruments & Supplies stocks, highest-scored first
Questions
What is LMAT's stock rating today?
LMAT scores 65/100 (Neutral) as of Nov 19, 2026: technical 37, fundamental 72. Scores are recomputed every night.
What does LeMaitre Vascular do?
LeMaitre Vascular (LMAT) makes and sells medical devices, implants and human tissue grafts used mainly by vascular surgeons to treat peripheral vascular disease. Its products include valvulotomes used to prepare veins for bypass grafts, catheters, carotid shunts, synthetic vascular grafts and bovine pericardial patches used to close arteries after surgery.
Is LMAT stock a buy?
The score is not a buy or sell recommendation. A 65 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the LMAT score calculated?
100 weighted scorers feed it today: 38 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.
Embed this score
A badge for a blog post, newsletter or README. It updates every night and links back here. More badges
HTML
<a href="https://stocksscores.com/stocks/lmat/"><img src="https://stocksscores.com/stocks/lmat/badge.svg" alt="LMAT stock score" height="20"></a>
Markdown
[](https://stocksscores.com/stocks/lmat/)